Capital Counsel’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.98M | Buy |
50,205
+13,125
| +35% | +$519K | 0.08% | 25 |
|
2025
Q1 | $1.12M | Hold |
37,080
| – | – | 0.05% | 30 |
|
2024
Q4 | $1.3M | Hold |
37,080
| – | – | 0.06% | 29 |
|
2024
Q3 | $1.49M | Hold |
37,080
| – | – | 0.06% | 28 |
|
2024
Q2 | $1.77M | Sell |
37,080
-2,500
| -6% | -$119K | 0.08% | 26 |
|
2024
Q1 | $1.72M | Sell |
39,580
-500
| -1% | -$21.7K | 0.08% | 25 |
|
2023
Q4 | $2.03M | Sell |
40,080
-150
| -0.4% | -$7.59K | 0.1% | 24 |
|
2023
Q3 | $1.82M | Hold |
40,230
| – | – | 0.1% | 25 |
|
2023
Q2 | $1.65M | Hold |
40,230
| – | – | 0.09% | 26 |
|
2023
Q1 | $1.44M | Hold |
40,230
| – | – | 0.08% | 27 |
|
2022
Q4 | $1.52M | Hold |
40,230
| – | – | 0.1% | 24 |
|
2022
Q3 | $1.78M | Sell |
40,230
-780
| -2% | -$34.5K | 0.12% | 22 |
|
2022
Q2 | $1.52M | Hold |
41,010
| – | – | 0.09% | 24 |
|
2022
Q1 | $1.52M | Buy |
41,010
+430
| +1% | +$15.9K | 0.07% | 27 |
|
2021
Q4 | $1.24M | Hold |
40,580
| – | – | 0.05% | 30 |
|
2021
Q3 | $1.36M | Hold |
40,580
| – | – | 0.07% | 28 |
|
2021
Q2 | $1.62M | Sell |
40,580
-1,500
| -4% | -$59.8K | 0.08% | 27 |
|
2021
Q1 | $1.89M | Hold |
42,080
| – | – | 0.11% | 24 |
|
2020
Q4 | $2.38M | Hold |
42,080
| – | – | 0.14% | 20 |
|
2020
Q3 | $2M | Buy |
42,080
+2,700
| +7% | +$128K | 0.13% | 21 |
|
2020
Q2 | $2.32M | Hold |
39,380
| – | – | 0.17% | 21 |
|
2020
Q1 | $1.86M | Hold |
39,380
| – | – | 0.15% | 23 |
|
2019
Q4 | $2.38M | Hold |
39,380
| – | – | 0.16% | 26 |
|
2019
Q3 | $2.36M | Hold |
39,380
| – | – | 0.17% | 25 |
|
2019
Q2 | $2.53M | Sell |
39,380
-5,000
| -11% | -$321K | 0.17% | 26 |
|
2019
Q1 | $3.6M | Buy |
44,380
+1,000
| +2% | +$81.2K | 0.26% | 25 |
|
2018
Q4 | $2.35M | Hold |
43,380
| – | – | 0.19% | 25 |
|
2018
Q3 | $2.24M | Hold |
43,380
| – | – | 0.16% | 29 |
|
2018
Q2 | $1.81M | Buy |
43,380
+1,000
| +2% | +$41.7K | 0.14% | 27 |
|
2018
Q1 | $1.87M | Buy |
42,380
+1,100
| +3% | +$48.5K | 0.15% | 27 |
|
2017
Q4 | $2.08M | Hold |
41,280
| – | – | 0.17% | 28 |
|
2017
Q3 | $2.09M | Hold |
41,280
| – | – | 0.19% | 27 |
|
2017
Q2 | $2.1M | Buy |
41,280
+3,250
| +9% | +$165K | 0.19% | 27 |
|
2017
Q1 | $1.53M | Buy |
38,030
+500
| +1% | +$20.1K | 0.15% | 31 |
|
2016
Q4 | $1.8M | Hold |
37,530
| – | – | 0.19% | 29 |
|
2016
Q3 | $1.38M | Buy |
37,530
+9,000
| +32% | +$330K | 0.12% | 30 |
|
2016
Q2 | $664K | Buy |
28,530
+10,100
| +55% | +$235K | 0.06% | 35 |
|
2016
Q1 | $746K | Buy |
18,430
+430
| +2% | +$17.4K | 0.07% | 34 |
|
2015
Q4 | $1.12M | Buy |
18,000
+5,000
| +38% | +$310K | 0.06% | 53 |
|
2015
Q3 | $525K | Hold |
13,000
| – | – | 0.03% | 70 |
|
2015
Q2 | $748K | Hold |
13,000
| – | – | 0.04% | 66 |
|
2015
Q1 | $828K | Hold |
13,000
| – | – | 0.04% | 63 |
|
2014
Q4 | $803K | Hold |
13,000
| – | – | 0.04% | 67 |
|
2014
Q3 | $505K | Buy |
13,000
+1,000
| +8% | +$38.8K | 0.03% | 78 |
|
2014
Q2 | $413K | Buy |
+12,000
| New | +$413K | 0.02% | 87 |
|